Skip to main content

Sleep Disorder Therapeutics Market Forecasted to Grow at Steady Pace During 2015-2021

Sleep disorders include a variety of complications related to sleep and have a high prevalence across the globe. Based on these complications, sleep disorders can be classified into three categories- lack of sleep which includes insomnia, excessive sleep which includes narcolepsy and disturbed sleep which include sleep apnea and Rapid eye movement (REM) disorder. Insomnia may arise as result of unhealthy diet, emotional dreams, stress, and many other factors.
Insomnia may affect reaction time towards common stimulus, hand-eye coordination, memory, and disturb daily life. Narcolepsy is a disorder that causes uncontrolled sleep at time period lasting less than minute or more than an hour. It has also been found that patients with narcolepsy experience sleep attacks more often during pregnancy, stress or ill health.
Request For Report Sample@ https://www.persistencemarketresearch.com/samples/5714
Usually narcolepsy is a genetic disease, but it has also been found to develop as a result of some neurological disorders or severe brain damage. REM sleep behavior disorder involves abnormal behavior in sleep. In this disorder, a patient dreaming about running, may run while still asleep. Sleep apnea is obstructed breathing during sleep.
According to a press release in March 2014 by World Association of Sleep Medicine, 45% of the global population suffers from some form of sleep disorder. It also mentions that approximately 25% male and 10% females in the U.S. suffer from sleep apnea. This high prevalence suggests an opportunity for a large therapeutics market.
Currently marketed drugs include Sanofi-Aventis manufactured Ambien (zolpidem), Sunovion Pharmaceuticals Inc.’s Lunesta (eszopiclone), Takeda Pharmaceutical’s Rozerem (ramelteon), Somaxon Pharmaceuticals, Inc.’s Silenor (doxepine) and various others. Over-the-counter drugs are also available for treating sleep disorder; these include
  • Nytol,
  • Sominex,
  • Compoz, and
  • Unisom.
Merck’s Suvorexant drug is an orexin receptor agonist which is under Phase III trial. Other companies involved in the drug development of sleep disorder include
  • Vanda Pharmaceuticals,
  • Eli Lilly,
  • GlaxoSmithKline and
  • Neurim Pharmaceuticals.
Request For Report Table of Content (TOC)@ https://www.persistencemarketresearch.com/toc/5714
Key geographies evaluated in this report are:
  • North America
    • U.S
    • Canada
  • Europe
    • France, Germany, Italy, Spain, and the UK
    • Eastern Europe
    • CIS
  • APAC
    • China
    • India
    • Japan
    • Australia
    • Others
  • Latin America
    • Argentina
    • Brazil
    • Others
Key features of this report
  • Drivers, restraints, and challenges shaping the Sleep Disorder Therapeutics market dynamics
  • Latest innovations and key events in the industry
  • Analysis of business strategies of the top players
  • Sleep Disorder Therapeutics market estimates and forecasts(2015 -2021)
Know More About Report@ https://www.persistencemarketresearch.com/market-research/sleep-disorder-therapeutics-market.asp
Labels:

Comments

Post a Comment

Popular posts from this blog

Development: Aerospace 3D Printing Market Strategy Planning by Top Manufacturers

  Aerospace 3D Printing Market Analysis 2026: According to a study of the Research Dive,  aerospace 3D printing market  forecast shall cross  $5,933.4 million by 2026 , growing at a  CAGR of 26.8%  during forecast period. Aerospace 3D printing is primarily used to increase the efficiency of A&D supply chain, reduction of storage costs of inventory and waste production materials. Furthermore, the Aerospace 3D printing industry is focusing more on creating parts of aircraft that are lighter and stronger than parts made by using traditional manufacturing. Astonishing advantages of 3D printings in the supply chain of the aerospace and defense industry are projected to surge in the global market. In addition, the financial support provided by the government and non-government organizations across the globe is also driving the 3D printing in aerospace industry. For instance,   National Aerospace Technology Exploitation Programme grants £140,000 funds for...
Post a Comment
Read more

Business analytics software increasing due to Low Cost & Enhanced Usability

  Business analytics software   conducts predictive analysis to derive decision-making inputs and insights through the application of statistical tools and methods in business performance data. It analyzes business data and information through continuous investigation and exploration of old business performance data to obtain decisive insights for business planning. A business analytics software helps an organization to optimize business operations and facilitates strategic decision-making. The outputs are mostly used by financial analysts, managers, security personnel, and key decision makers of organizations. The demand for cloud-based business analytics software is increasing among small- and medium-sized enterprises chiefly due to its low cost and enhanced usability. Request for Sample Copy @  https://bit.ly/3gRxTjw The growth of the global business analytics software market is driven by factors such as increase in adoption of business analytics software by multiple o...
Post a Comment
Read more

Digital Banking System Market Size, Cost Structure, Market Status and Forecasts to 2026

  The world is facing an unexpected change and many of the industries are experiencing thought provoking situation due to the COVID-19 pandemic. Previous to the COVID-19 pandemic, there was high growth rate in digital banking market. But, since the occurrence of COVID- 19 outbreak it has been witnessed that digital banking has faced dual impact. The reason behind of this impact is the banks can utilize this disruption time as an opportunity for them by analyzing the need and importance of technologies to make their product and services digitalize across the globe. On the other side, larger use of technologies reduces completely the dependency on manual entities, person led reviews i.e. paper and employee intervention within banks. For example, According to RBI, for the financial year 2017-18, India’s banking sector witnessed a spike in cyber frauds and pegged the losses at $ 13.7 billion. With increased use of cashless and digital economy, it will be imperative for the banks to imp...
Post a Comment
Read more